MEI Pharma (MEIP) Competitors

MEI Pharma (NASDAQ:MEIP) and Repare Therapeutics (NASDAQ:RPTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership.

Does the MarketBeat Community prefer MEIP or RPTX?

MEI Pharma received 380 more outperform votes than Repare Therapeutics when rated by MarketBeat users. However, 64.18% of users gave Repare Therapeutics an outperform vote while only 63.32% of users gave MEI Pharma an outperform vote.

Company	Underperform	Outperform
MEI Pharma	Outperform Votes 423 63.32%	Underperform Votes 245 36.68%
Repare Therapeutics	Outperform Votes 43 64.18%	Underperform Votes 24 35.82%

Do analysts rate MEIP or RPTX?

Repare Therapeutics has a consensus target price of $4.50, suggesting a potential upside of 212.50%. Given Repare Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Repare Therapeutics is more favorable than MEI Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MEI Pharma	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Repare Therapeutics	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Is MEIP or RPTX more profitable?

MEI Pharma has a net margin of 0.00% compared to Repare Therapeutics' net margin of -99.76%. Repare Therapeutics' return on equity of -40.87% beat MEI Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MEI Pharma	N/A	-84.92%	-67.53%
Repare Therapeutics	-99.76%	-40.87%	-35.07%

Which has more volatility and risk, MEIP or RPTX?

MEI Pharma has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. Comparatively, Repare Therapeutics has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500.

Does the media prefer MEIP or RPTX?

In the previous week, MEI Pharma had 1 more articles in the media than Repare Therapeutics. MarketBeat recorded 3 mentions for MEI Pharma and 2 mentions for Repare Therapeutics. Repare Therapeutics' average media sentiment score of 0.93 beat MEI Pharma's score of 0.43 indicating that Repare Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MEI Pharma	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Repare Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals believe in MEIP or RPTX?

52.4% of MEI Pharma shares are held by institutional investors. Comparatively, 85.1% of Repare Therapeutics shares are held by institutional investors. 3.1% of MEI Pharma shares are held by insiders. Comparatively, 11.5% of Repare Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has preferable valuation and earnings, MEIP or RPTX?

MEI Pharma has higher revenue and earnings than Repare Therapeutics. MEI Pharma is trading at a lower price-to-earnings ratio than Repare Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MEI Pharma	$65.30M	0.24	$17.78M	-$4.75	-0.49
Repare Therapeutics	$1.07M	57.56	-$93.80M	-$3.01	-0.48

Summary

Repare Therapeutics beats MEI Pharma on 12 of the 18 factors compared between the two stocks.